Back to Mobile View
AOL.com Search Video - Biotech Stocks
Welcome, Sign In
Make AOL My Homepage
Huffington Post Sports
Find a video
1 - 12
Biotech's Next Big Thing: Earnings
It's time to review the mid-cap biotech stocks reporting second quarter results next week, says Adam Feuerstein, Sr. Columnist at TheStreet.
August 04, 2013
The Potential of Biotech Stock
After a strong runup from our recommendation, is it time to take money off the table in Lexicon Pharmaceuticals?
June 06, 2010
Europe Stocks Set for Surge, M&A Will Boos...
The big themes investors should jump on in 2014 are Europe's recovery, increased global M&A, and another big year for biotech and technology stocks, s...
January 19, 2014
Stem Cell Stocks Seek Comeback
Don't expect stem cell stocks to lag the rest of the biotech sector again in 2014, says Dr. Robin Smith, CEO of Neostem.
December 09, 2013
Boston Therapeutics' New Tablet Reduces Su...
Boston Therapeutics has a new tablet PAZ320 designed to reduce a person's sugar intake by 40 percent. CEO Dr. David Platt believes the tablet will eve...
December 20, 2013
Two Small Cap Biotechs to Bet On
Merrimack and Threshold Pharmaceuticals will soon announce catalysts to propel their stocks, says Rob Goldman of Goldman Small Cap Research.
October 15, 2013
Unilife Strutting Over Sanofi Deal
Syringe-seller Unilife is gaining momentum - and scaring the shorts - after signing a big deal with Sanofi, says Alan Shortall, CEO of Unilife.
September 15, 2013
ETN, HAIN, CELG: 3 Stocks on TV
Dan Fitzpatrick, founder of StockMarketMentor.com, details three stocks Jim Cramer discussed on CNBC's "Mad Money" and how to trade them.
August 25, 2013
Future of Infertility Treatment
Infertility rates are on the raise as women wait longer to have a baby. Dr Michelle Dipp explains why OvaScience could be a game changer.
September 08, 2013
Revolutionizing Diabetes Treatment
This biotech company is seeking to revolutionize the treatment of diabetes. Nadav Kidron reviews Oramed's proprietary product.
September 01, 2013
Are Onyx and Alexion Next?
Jim Cramer looks at the implications of the latest biotech deal, Cubist acquiring Trius, and the implications for the biotech sector.
August 01, 2013
Controversy Won't Stop Intuitive Surgical
Intuitive Surgical may be a battleground stock, but it has the fundamentals to win the war, says Tao Levy, Managing Director at Wedbush Securities.
August 14, 2013
7 Fashion Staples That Transition From Winte...
President Obama Shows Off Comedy Chops
'Supernanny' Jo Frost's Tips for Parenting...
Back to Top
Help & Feedback
About Our Ads
© 2014 AOL Inc.
All Rights Reserved.